A new White House order aiming to rein in proxy advisory firms marks a major step in a broader Republican effort to weaken ...
Becton Dickinson and Co, iShares U.S. Pharmaceuticals ETF, BlackRock Health Sciences Trust. Read 's Market Analysis on Investing.com ...
Ingredion remains a Buy supported by robust financials, cost savings, and strong shareholder returns despite recent earnings ...
Shares have tumbled in Asia and U.S. futures also fell ahead of the release of U.S. employment and inflation reports that ...
Stocks drifted lower and the dollar hovered near two-month lows as investors stayed cautious ahead of key US economic data ...
Few investors have more notoriety than Bill Ackman and Michael Burry, the latter portrayed in "The Big Short." ...
Wall Street is edging lower at the start of a week full of economic reports that could drive where interest rates, and thus ...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” ...
Wall Street is rising at the start of a week full of economic reports that could drive where interest rates, and thus stock prices, go. The ...
Its shares have declined by 50% over this period. But Pfizer's path to a rebound (unlike Teladoc's) seems clear. Even aside ...
Billionaire Mark Cuban has long championed the idea that kids should start saving early to secure their futures. Drawing from ...
NewLake Capital Partners, Inc. is a top choice for cannabis rescheduling. Click for why I see NLCP as a better play than AdvisorShares Pure US Cannabis ETF (MSOS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback